Moderna | MRNA - Ordinary Share Capital



Moderna reported $389M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 167.36M 167.35M Jun/2025
Adcock Ingram Holdings ZAR 14.68M 0 Dec/2024
Agios Pharmaceuticals USD 58.04M 57.96M Jun/2025
Alnylam Pharmaceuticals USD 130.98M 129.67M Jun/2025
Amgen USD 538M 33.04B Jun/2025
Arrowhead Research USD 138.14M 137.91M Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
BioMarin Pharmaceutical USD 192M 191.81M Jun/2025
Celltrion KRW 230.8B 10.29B Mar/2025
Cspc Pharmaceutical CNY 11.03B 26.91M Dec/2024
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Divis Laboratories Ltd 530M 0 Mar/2025
Gilead Sciences USD 1.24B 3M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Incyte USD 194.12M 193.93M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 3.24M 0 Jun/2023
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 389M 388.96M Jun/2025
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Pharma Mar EUR 17.58M 6.64M Jun/2025
Qiagen NV USD 216.83M 214.3M Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Sarepta Therapeutics USD 97.71M 97.7M Jun/2025
Sartorius EUR 69.04M 38.2K Jun/2025
Sino Biopharmaceutical CNY 414.38M 0 Dec/2024
Tilray USD 93K 5K Nov/2024
Ultragenyx Pharmaceutical USD 96.35M 2.45M Jun/2025
United Therapeutics USD 45.22M 44.42M Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025
Zz Pientze Pharmaceu 603.32M 0 Jun/2025